Xinyuan Zhang1,2, Liang Ye1,2, Hao Xu2,3, Qin Zhou1,2, Bin Tan1,2, Qin Yi1,2, Liang Yan1,2, Min Xie1,2, Yin Zhang1,2, Jie Tian2,4, Jing Zhu5,6. 1. Department of Pediatric Research Institute, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders (Chongqing), China International Science and Technology Cooperation base of Child development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, Box 136, No. 3 Zhongshan RD, Yuzhong district, Chongqing, 400014, People's Republic of China. 2. Chongqing Key Laboratory of Pediatrics, Chongqing, People's Republic of China. 3. Department of Clinical Laboratory, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders (Chongqing), China International Science and Technology Cooperation base of Child development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, People's Republic of China. 4. Department of Cardiovascular (Internal Medicine), Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders (Chongqing), China International Science and Technology Cooperation base of Child development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, People's Republic of China. 5. Department of Pediatric Research Institute, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders (Chongqing), China International Science and Technology Cooperation base of Child development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, Box 136, No. 3 Zhongshan RD, Yuzhong district, Chongqing, 400014, People's Republic of China. jingzhu@cqmu.edu.cn. 6. Chongqing Key Laboratory of Pediatrics, Chongqing, People's Republic of China. jingzhu@cqmu.edu.cn.
Abstract
BACKGROUND: Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) hold great promise for regenerative medicine and in drugs screening. Despite displaying key cardiomyocyte phenotypic characteristics, they more closely resemble fetal/neonatal cardiomyocytes and are still immature; these cells mainly rely on glucose as a substrate for metabolic energy, while mature cardiomyocytes mainly employ oxidative phosphorylation of fatty acids. Studies showed that the alteration of metabolism pattern from glycolysis to oxidative phosphorylation improve the maturity of hiPSC-CMs. As a transcription factor, accumulating evidences showed the important role of NRF2 in the regulation of energy metabolism, which directly regulates the expression of mitochondrial respiratory complexes. Therefore, we hypothesized that NRF2 is involved in the maturation of hiPSC-CMs. METHODS: The morphological and functional changes related to mitochondria and cell maturation were analyzed by knock-down and activation of NRF2. RESULTS: The results showed that the inhibition of NRF2 led to the retardation of cell maturation. The activation of NRF2 leads to a more mature hiPSC-CMs phenotype, as indicated by the increase of cardiac maturation markers, sarcomere length, calcium transient dynamics, the number and fusion events of mitochondria, and mitochondrial respiration. Bioinformatics analysis showed that in addition to metabolism-related genes, NRF2 also activates the expression of myocardial ion channels. CONCLUSIONS: These findings indicated that NRF2 plays an important role in the maturation of hiPSC-CMs. The present work provides greater insights into the molecular regulation of hiPSC-CMs metabolism and theoretical basis in drug screening, disease modeling, and alternative treatment.
BACKGROUND: Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) hold great promise for regenerative medicine and in drugs screening. Despite displaying key cardiomyocyte phenotypic characteristics, they more closely resemble fetal/neonatal cardiomyocytes and are still immature; these cells mainly rely on glucose as a substrate for metabolic energy, while mature cardiomyocytes mainly employ oxidative phosphorylation of fatty acids. Studies showed that the alteration of metabolism pattern from glycolysis to oxidative phosphorylation improve the maturity of hiPSC-CMs. As a transcription factor, accumulating evidences showed the important role of NRF2 in the regulation of energy metabolism, which directly regulates the expression of mitochondrial respiratory complexes. Therefore, we hypothesized that NRF2 is involved in the maturation of hiPSC-CMs. METHODS: The morphological and functional changes related to mitochondria and cell maturation were analyzed by knock-down and activation of NRF2. RESULTS: The results showed that the inhibition of NRF2 led to the retardation of cell maturation. The activation of NRF2 leads to a more mature hiPSC-CMs phenotype, as indicated by the increase of cardiac maturation markers, sarcomere length, calcium transient dynamics, the number and fusion events of mitochondria, and mitochondrial respiration. Bioinformatics analysis showed that in addition to metabolism-related genes, NRF2 also activates the expression of myocardial ion channels. CONCLUSIONS: These findings indicated that NRF2 plays an important role in the maturation of hiPSC-CMs. The present work provides greater insights into the molecular regulation of hiPSC-CMs metabolism and theoretical basis in drug screening, disease modeling, and alternative treatment.
Authors: John Antonydas Gaspar; Michael Xavier Doss; Jan Georg Hengstler; Cristina Cadenas; Jürgen Hescheler; Agapios Sachinidis Journal: Circ Res Date: 2014-04-11 Impact factor: 17.367
Authors: Cláudia Correia; Alexey Koshkin; Patrícia Duarte; Dongjian Hu; Madalena Carido; Maria J Sebastião; Patrícia Gomes-Alves; David A Elliott; Ibrahim J Domian; Ana P Teixeira; Paula M Alves; Margarida Serra Journal: Biotechnol Bioeng Date: 2017-12-11 Impact factor: 4.530
Authors: Abena S Agyeman; Raghothama Chaerkady; Patrick G Shaw; Nancy E Davidson; Kala Visvanathan; Akhilesh Pandey; Thomas W Kensler Journal: Breast Cancer Res Treat Date: 2011-05-20 Impact factor: 4.872
Authors: Chrishan J A Ramachandra; Ashish Mehta; Philip Wong; K P Myu Mai Ja; Regina Fritsche-Danielson; Ratan V Bhat; Derek J Hausenloy; Jean-Paul Kovalik; Winston Shim Journal: Int J Cardiol Date: 2018-08-24 Impact factor: 4.164